PATENT CLAIM ANALYSIS

Application Number: 15881581
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["435", "005000"]

Abstract:
Provided herein are novel irreversible sialidase inhibitors. These compounds can be conjugated with a detectable tagging moiety such as azide-annexed biotin via CuAAC for isolation and identification of sialidases. The provided compounds and the corresponding detectable conjugates are useful for detecting sialidase-containing pathogens and imaging in situ sialidase activities under physiological conditions.

Claim (Index 92):
The compound of  claim 80 , wherein the F atom at the C3-position is equatorial.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.19565
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14422310', '13662002', '15721393', '15104132', '15847430']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6344721812680377
- 35 USC 102 Novelty (BERT): 0.5893554815791517
- Combined Prediction Score: 0.6299605112991491
- Mean Citation Score: 408.304482
- Max Citation Score: 581.6555
- Similarity Product: 362.6438233823776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test